How I diagnose and treat neutropenia
- PMID: 26554885
- PMCID: PMC4668211
- DOI: 10.1097/MOH.0000000000000208
How I diagnose and treat neutropenia
Abstract
Purpose of review: Neutropenia absolute neutrophil count (ANC) less than 1.5 × 10(9)/l is a common hematological finding, and severe neutropenia, that is, ANC less than 0.5 × 10(9)/l is a well known risk factor for susceptibility to bacterial infections. This review provides a succinct clinical approach to the diagnosis and treatment of neutropenia with specific recommendations on the treatment of severe chronic neutropenia with the myeloid growth factor, granulocyte colony-stimulating factor (G-CSF).
Recent findings: Experts agree that patients with acute febrile neutropenia should be treated with antibiotics and that patients at high risk of severe neutropenia (>20% risk) after myelosuppressive chemotherapy should be treated prophylactically with a myeloid growth factor, usually G-CSF. The diversity of causes and consequences of chronic neutropenia make the diagnosis and management of these patients more complicated.
Summary: The review provides a stepwise approach to neutropenia focusing first on reaching a provisional diagnosis and treatment plan then steps to a final diagnosis. It also provides specific recommendations on the treatment of severe chronic neutropenia with G-CSF.
References
-
- Gibson C, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014;124:1251–8. - PubMed
-
- ** A timely review and practical approach to the evaluation of adult neutropenia patients, focusing on the outpatient setting.
-
- ** A practical review of the diagnosis and treatment of acute and chronic neutropenia in adults, particularly the elderly, following step by step evaluation and diagnosis in a specific case.
-
- Walkovich K, Boxer LA. How to approach neutropenia in childhood. Pediatr Rev. 2013;34:173–84. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
